Isolation and Characterization of Renal Erythropoietin-Producing Cells from Genetically Produced Anemia Mice by Pan, Xiaoqing et al.
Isolation and Characterization of Renal Erythropoietin-
Producing Cells from Genetically Produced Anemia Mice
Xiaoqing Pan
1, Norio Suzuki
1, Ikuo Hirano
1, Shun Yamazaki
1, Naoko Minegishi
2, Masayuki Yamamoto
1*
1Department of Medical Biochemistry, Tohoku University Graduate School of Medicine, Sendai, Miyagi, Japan, 2School of Nursing, Miyagi University, Sendai, Miyagi,
Japan
Abstract
Understanding the nature of renal erythropoietin-producing cells (REPs) remains a central challenge for elucidating the
mechanisms involved in hypoxia and/or anemia-induced erythropoietin (Epo) production in adult mammals. Previous
studies have shown that REPs are renal peritubular cells, but further details are lacking. Here, we describe an approach to
isolate and characterize REPs. We bred mice bearing an Epo gene allele to which green fluorescent protein (GFP) reporter
cDNA was knocked-in (Epo
GFP) with mice bearing an Epo gene allele lacking the 39 enhancer (Epo
D39E). Mice harboring the
mutant Epo
GFP/D39E gene exhibited anemia (average Hematocrit 18% at 4 to 6 days after birth), and this perinatal anemia
enabled us to identify and purify REPs based on GFP expression from the kidney. Light and confocal microscopy revealed
that GFP immunostaining was confined to fibroblastic cells that reside in the peritubular interstitial space, confirming our
previous observation in Epo-GFP transgenic reporter assays. Flow cytometry analyses revealed that the GFP fraction
constitutes approximately 0.2% of the whole kidney cells and 63% of GFP-positive cells co-express CD73 (a marker for
cortical fibroblasts and Epo-expressing cells in the kidney). Quantitative RT-PCR analyses confirmed that Epo expression was
increased by approximately 100-fold in the purified population of REPs compared with that of the unsorted cells or CD73-
positive fraction. Gene expression analyses showed enrichment of Hif2a and Hif3a mRNA in the purified population of REPs.
The genetic approach described here provides a means to isolate a pure population of REPs, allowing the analysis of gene
expression of a defined population of cells essential for Epo production in the kidney. This has provided evidence that
positive regulation by HIF2a and negative regulation by HIF3a might be necessary for correct renal Epo induction. (282
words)
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Introduction
Erythropoietin (Epo) governs mammalian erythropoiesis. Epo is
a glycoprotein hormone mainly produced in the kidney and liver
in response to changes in tissue oxygen tension. Epo regulates
erythropoiesis by supporting the survival of erythroid progenitors
and stimulating their differentiation and proliferation in bone
marrow, hence increasing the oxygen-carrying capacity of blood
[1]. Lack of Epo during mouse development leads to lethality at
embryonic day 13.5 (E13.5) due to severe anemia [2] and over- or
under-production of Epo results in polycythemia or anemia
clinically [1]. Epo production is considered to be controlled
primarily at the level of gene transcription and Epo gene expression
is strictly regulated in a tissue/cell-specific and hypoxia/anemia-
induced manner [3–7].
Several tissues have been reported to express the Epo gene; but
the ability to produce substantial amounts of Epo during hypoxia/
anemia is restricted to the fetal liver and adult kidney [4–8]. The
kidney plays a major role in oxygen sensing and contributes ,90%
of plasma Epo in adult animals [9]. However, difficulties in
identification and purification of the renal Epo-producing cells
(REPs) have limited the understanding of the mechanism for
controlling Epo production in kidney. REPs are frequently
reported to be peritubular fibroblast-like cells in kidney
[6,10,11]; and a hypoxia-dependent Epo-producing cell line
derived from human renal cancer was also described recently to
exhibit fibroblast-like phenotype [12]. However, further details
remain to be elucidated [5,7,13].
Current knowledge of the molecular mechanisms of oxygen-
sensing and renal Epo gene expression has been extrapolated
mostly from in vitro studies in hepatoma cell lines [14–16]. These
studies have suggested that hypoxia responsiveness of the Epo gene
depends on an enhancer containing hypoxia-responsive elements
(HREs) located in the 39 flanking region of the gene (39 enhancer),
to which the hypoxia-inducible transcription factor (HIF) 1 binds.
HIF1 is composed of two subunits, HIF1a and HIF1b. HIF1b is
constitutively expressed, but HIF1a expression, almost absent in
normoxia, is increased during hypoxia. Under normoxic condi-
tions, HIF1a is hydroxylated at two proline residues by specific
prolyl-4-hydroxylases (PHD1–3) that allow the E3 ubiquitin ligase
von Hippel-Lindau (pVHL) to bind to HIF1a and mark it for
proteasomal degradation. In addition, HIF1a is regulated by the
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inhibits p300/CBP (CREB-Binding Protein) binding to HIF1a.
The activities of PHD and FIH1 are basically dependent on
cellular oxygen concentration and thus qualify as cellular oxygen
sensors. Low oxygen tension causes inactivation of PHDs and
FIH1, allows HIFa to accumulate, forms active transcription
factor-complex HIF with HIF1b, recruits transcriptional cofactors,
and initiates the transcription of hypoxia responsive genes
including the Epo gene. Thus the PHD/pVHL/HIF system likes
to be the oxygen-sensing pathway regulating Epo gene transcrip-
tion [17].
However, recent clinical and in vivo studies have suggested a
new layer of complexity to the mechanisms involved in the
cellular response to hypoxia/anemia. Evidence from mouse
models and hereditary erythrocytosis in humans has revealed
that HIF2a rather than HIF1a plays a vital role in oxygen-
regulated erythropoiesis and renal Epo production is probably
regulated by PHD2/pVHL/HIF2a pathway [13,18,19]. There
are three HIFa family members: HIF1a,H I F 2 a,a n dH I F 3 a,
which share a number of similarities e.g. DNA-binding sequence,
oxygen-dependent hydroxylation. Unlike ubiquitously expressed
HIF1a,e x p r e s s i o no fH I F 2 a and HIF3a is limited to several
tissues [20]. Both HIF1a and HIF2a activate transcription,
while HIF3a negatively regulates HIF1a and HIF2a activity
[20–22]. There is no literature on HIF3a’s role in hematopoiesis
thus far.
In order to clarify the whole picture of Epo gene regulation, we
have generated a panel of mouse lines. First, we genetically deleted
the 39 enhancer (referred to as the Epo
D39E allele) and showed that
this enhancer is necessary for hepatic Epo expression during the
perinatal period {E17–postnatal day 13 (P13)} but dispensable for
renal Epo expression after birth. Mice homozygous for the targeted
allele (Epo
D39E/D39E) are viable and fertile, but exhibit anemia
during late-embryonic and newborn stages [23]. Then, using a
180-kb Epo transgene with a green fluorescent protein (GFP)
reporter (Epo-GFP), we recapitulated tissue-specific, hypoxia-
inducible GFP expression in kidney and liver tissue of mouse.
Mutation studies on the transgene indicated that GATA factors
are required for suppression of ectopic expression of the gene, but
not essential for the Epo gene induction in REPs [6]. Also, we
developed GFP knock-in mice (Epo
GFP/wt) by homologous
recombination in mouse embryonic stem cells (NS and MY,
unpublished data). By examining these mouse lines, we identified
GFP-labeled REPs as a population of peritubular interstitial cells
in the kidney after birth.
Taken together, all these data in vivo strongly imply novel
mechanism(s) and necessitate detailed studies on REPs to explore a
specific oxygen-sensing pathway underlying the hypoxia-induced
Epo production in the kidney.
Fluorescence activated cell sorting (FACS) of GFP expressing
cells has been widely used for the isolation of hematopoietic stem
cells in our laboratory [24,25]. To make the link between the
molecular and cellular mechanisms of hypoxia-induced Epo
expression, in this paper, we have addressed controversial issues
in REPs using cell-sorting techniques. Our Epo-GFP transgenic
mice are a source of REPs isolation, but a pretreatment to
induce anemia is not always successful for stable GFP expression
in the kidney [6]. We therefore generated Epo
GFP/D39E mice, in
which REPs were labeled with GFP as a result of neonatal
anemia caused by genetic modifications. Taking advantage of
the strong GFP expression in anemic newborns carrying the 39
enhancer deletion, we have purified by FACS a cell population
responsible for anemia/hypoxia induced Epo expression in the
kidney.
Results
Generation of Epo
GFP/D39E Mice
We first tried to define REPs by GFP fluorescence, which
truthfully reflects endogenous Epo expression. We have established
Epo
GFP/wt mice by homologous recombination. In our Epo
GFP/wt
mice, the Epo locus was targeted by replacing the 39 part of exon 2
through exon 4 with GFP (Figure 1A, middle panel). The mice
homozygous for Epo
GFP/GFP, which lacked a functional Epo gene,
died around E13.5 from anemia, corresponding with the previous
report on a Epo gene knockout mouse [2]. The heterozygous
animals (Epo
GFP/wt) were healthy and fertile; and distinct GFP
expression, mimicking the endogenous Epo expression pattern, was
observed in the kidney and liver under hypoxia/anemia conditions
(NS and MY, unpublished data).
For steady Epo induction, we set out to genetically produce an
anemia model by taking advantage of our established Epo
D39E/D39E
mice (Figure 1A, lower panel). As we previously reported in
Epo
D39E/D39E mice, deletion of the 39 enhancer provokes transient
anemia at late embryonic and neonatal stages due to defect in
hepatic Epo production and erythropoiesis. This anemic pheno-
type is recovered in 2 weeks after birth when major Epo
production site switches from the liver to kidney [23]. Cros-
sing an Epo
GFP/wt heterozygote with a mouse homozygous for
Epo
D39E/D39E allele, we generated Epo
GFP/D39E compound offspring.
The compound mice basically showed a similar phenotype to that
of their Epo
D39E/D39E parents: anemia persisting after birth and
recovered in the juvenile stage. Epo
GFP/D39E newborns were
severely pale compared with Epo
D39E/wt littermates (Figure 1B).
At P4–6, the Hematocrit (Hct) of the Epo
D39E/D39E and Epo
GFP/D39E
newborns were 22.765.3 and 18.062.0 (%), respectively
(Figure 1C). At the same stage, the Hct of the Epo
D39E/wt control
was 32.064.1%; this value is comparable with that of wild type
(data not shown). Increased Epo mRNA could be detected in the
kidney of the Epo
GFP/D39E newborns by quantitative (q) RT-PCR
(see below).
Cellular distribution of GFP expression in anemic
neonatal kidneys
We then examined newborn (P4–6) kidneys to see GFP
expression by immunostaining studies. In microscopic observation
of the kidney section with anti-GFP immunostaining, fluorescence
was minimal in control kidney samples from P4–6 Epo
D39E/wt
littermates, but was prominent in the kidneys from the Epo
GFP/D39E
mice (Figure 2A,B). GFP fluorescence was also directly detected in
fixed Epo
GFP/D39E kidney slices by confocal microscopy (data not
shown). GFP signals were confined to the cortex-medulla junction
and focally distributed along the curve of the kidney at P4–6
(Figure 2B). GFP-expressing cells were stellate-shaped, nesting
around proximal tubules in the deep cortical labyrinth and outer
strip area of the kidney (Figure 2C,D). These findings are
consistent with previous descriptions [5,6,26,27] and indicate that
the GFP expression reflects the endogenous expression of the Epo
gene in kidneys of anemic Epo
GFP/D39E newborns.
Cell type of the GFP-expressing kidney cells in Epo
GFP/D39E
newborns
Kidney interstitium contains mainly fibroblastic, dendritic cells
[28], and vascular endothelial as well as tubular cells have also
been identified as the site of Epo gene expression in the kidney
[5]. We therefore carried out marker studies on GFP-expressing
kidney cells of P4–6 anemic newborns by dual immunostaining
under confocal microscopy and FACS detection (Table 1).
Expression of platelet-derived growth factor receptor b
Renal Epo-Producing Cells (REPs)
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(Figure 4), but not CD31 (Figure 3A), major histocompatibility
complex class II (MHCII) (Figure 3B), or E-cadherin (Movie S1),
indicated that REPs are cortical fibroblast-like, but not tubular,
endothelial, or dendritic cells. Our three-dimensional (3D) movie
reveals that REPs are tightly packed around tubules, but not
tubular cells themselves (Movie S1). We also examined the
expression of alpha-smooth muscle actin (a-SMA), a marker for
the subtype of renal interstitial fibroblasts [28]. Staining with a-
SMA antibody was observed in the medullar and cortical cells
near the capsule, but did not overlap with GFP-positive cells
(Figure 3D). Taken together, most neonatal REPs at P4–6 stage,
are CD73-, PDGFRb-positive, a-SMA-negative peritubular
fibroblasts (Table 1). Thus, neonatal REPs have the typical
characteristics of adult cortical fibroblasts previously reported in
healthy rat kidney [29].
CD73 is considered to be a reliable marker for identification of
renal cortical fibroblasts [27], and Epo-expressing cells
[6,11,12,28,30]. In the kidney sections of P4–6 Epo
GFP/D39E
newborns, roughly 60%, but not all of GFP-positive cells,
expressed CD73. Therefore, GFP-positive cells were divided into
CD73
+ and CD73
2 populations (Figure 4A–C). Both CD73
+ and
CD73
2 GFP-expressing cortical interstitial cells were remarkably
increased in Epo
GFP/D39E neonates (Figure 4C) compared with in
Epo
D39E/wt littermates (Figure 4D). In Epo
D39E/wt non-anemic
kidney, only a few GFP-expressing cells constituting both CD73
+
and CD73
2 were observed and located in the juxtamedullary
layer of the cortex (Figure 4D).
Unlike GFP signals, which were restricted to peritubular
interstitium, CD73 stains were widely spread in the renal cortex.
Besides fibroblasts, proximal tubule (brush boarder), glomeruli
(mesangial cells) and the cells in the medullar rays were also
observed to express CD73 in sections. The proportion of CD73
expressing cells and their staining intensity in non-fibroblast cells
were similar in both anemic and non-anemic kidney sections
(Figure 4C, D), i.e. among various types of CD73-expressing
kidney cells, only cortical fibroblasts showed a hypoxia/anemia-
responsive tendency.
FACS sorting of GFP
+ cells and Epo mRNA expression in
the isolated cells
We isolated GFP
+ cells from the kidneys of P4–6 Epo
GFP/D39E
neonates by flow cytometry. Kidney cells from Epo
D39E/wt
littermates were used as negative controls (Figure 5B, upper-left
panel). The GFP
+ population was present grossly with a low to
intermediate GFP intensity and constituted up to 0.2% of the total
fresh kidney cells (Figure 5B, upper-right panel). This yielded
several thousands viable GFP
+ cells per Epo
GFP/D39E mouse at P4–6
newborn stage, with a purity of greater than 75%. We also
assessed the association of GFP-expressing cells with CD73. As
shown in Figure 5B, lower-right panel, of GFP
+ cells from P4–6
anemic kidneys, 63% were CD73
+ and 37% were CD73
2.A
confocal microscopic image of the sorted GFP
+ cells is shown with
anti-GFP immunostaining (Figure 5C).
Subsequently, we evaluated the expression of Epo mRNA in
each sorted fraction from P4–6 Epo
GFP/D39E kidneys, and in
Figure 1. Generation of Epo
GFP/D39E mouse. A Diagram shows structures of the wild type (wt, upper), Epo
GFP (middle) and Epo
D39E (lower),
respectively. IRES, internal ribosomal entry site. B,C An Epo
GFP/wt heterozygote and an Epo
D39E/D39E homozygote were bred to obtain the compound
Epo
GFP/D39E genotype. Epo
GFP/D39E mice exhibited transient anemia during the perinatal stage: B at P5 looked pale; C presented a decreased Hct value
even lower than that of Epo
D39E/D39E at P4–P6 stage. The Epo
D39E/wt littermates were used as a normal control. *p,0.05.
doi:10.1371/journal.pone.0025839.g001
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D39E/wt and Epo
GFP/D39E newborns as
well. The hypoxanthine-phosphoribosyl-transferase (Hprt)g e n ew a s
used as a loading control, because expression of HPRT is less affected
by hypoxia/anemia [31]. As shown in Figure 5D, qRT–PCR
revealed high Epo mRNA expression exclusively in samples from
Epo
GFP/D39E animals including unsorted kidney cells, CD73
2,C D 7 3
+
and GFP
+ subsets. In Epo
GFP/D39E mice, compared with the unsorted
kidney, Epo mRNA levels were ,100 fold enriched in the GFP
+
fraction, but not in the CD73
+ fraction. Epo mRNA expression was
low but detectable in Epo
D39E/wt kidney cells at P4–6, but not in the
GFP-negative fraction of Epo
GFP/D39E kidney cells (Figure 5D). We
havereported that neuronal markers areexpressed by Epo-producing
cells in the adult kidney [6]. Consistently, transcripts for microtubule-
associated protein 2 (MAP2) and neurofilament light polypeptide
(NFL) were detected in the GFP
+ fraction from P4–6 Epo
GFP/D39E
kidneys (data not shown). These results demonstrate our system for
isolation of REPs is reliable and efficient.
Gene expression profile of oxygen-sensing and HIFs of
the isolated REPs
We examined the expression of molecules, known to be involved
in oxygen tension-dependent regulation [19], by qRT-PCR
analysis. Compared to GFP-negative kidney cells, no enrichment
of mRNA expression of oxygen sensor genes, Phd1–3 and Fih1
genes was found in the REPs fraction (Figure 6A). Hif2a but not
Hif1a (Figure 6B, upper panel) mRNA expression was up-
regulated in the REPs. In this line, no enrichment of HIF1a
target genes [4], Pgk1 and Phd2, Phd3 were found in the REPs.
These are consisted with recent reports on the relationship of
HIF2a to renal Epo production [12,29,32,33].
Figure 2. GFP expression in the anemic kidney of Epo
GFP/D39E mouse. Representative photos of P5 neonates: kidney slices A from a
nonanemic Epo
D39E/wt littermate as a negative control; B–D from Epo
GFP/D39E newborns. Light and confocal microscopy revealing the GFP signal
concentrated in the deep-cortex,outer-medulla region (B), where the Epo-producing peritubular interstitial cells are localized (C,D). Anti-GFP
signals: green (Alexa 488), and dark-brown (diaminobenzidine). Scale bars: 25 mm. The sketch at the bottom illustrates peritubular localization of the
GFP-expressing cells in the kidney.
doi:10.1371/journal.pone.0025839.g002
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((Figure 6B, upper right panel). In the three alternatively spliced
variants of Hif3a mRNA: Ipas, Nepas and Hif3a, Nepas is expressed
during infantile and newborn stages, while Ipas is seen in adults. In
accordance with a reported method [34,35], we examined the
expression of these splice variants in REPs, and detected all three
variant mRNAs in the fraction of REPs at P4–6 stage. Nepas
mRNA expression was the highest, suggesting Nepas might be a
dominant form among the three splicing variants of the Hif3a at
P4–6 infantile stage (Figure 6C).
Discussion
By generating Epo
GFP/D39E mice, we isolated a specific type of
renal cells namely REPs, which are responsible for Epo production
after birth. REPs 1) are fibroblast-like interstitial cells residing in
the tubulo-interstitial compartment of the kidney in anemic hosts
(Hct 18%); 2) constitute up to 0.2% of whole kidney cells. About
63% of REPs also express CD73, a marker for cortical fibroblasts
and Epo-expressing cells in kidney [6,10,28,30]; 3) highly express
Hif2a, Hif3a, but not Hif1a mRNAs; 4) are efficiently isolated from
naive kidney tissues as GFP-expressing cells in our mutant.
Isolation system of REPs
Previously, difficulties in the isolation of REPs prevented better
understanding of the mechanisms of Epo regulation in response to
hypoxia. We developed an isolation system that phenotypically
labeled REPs in the kidney, by way of a GFP knock-in (Epo
GFP)
combined with a 39 enhancer (Epo
D39E). This enabled us to purify
REPs, a rare cell population, from kidney by FACS-sorting.
Our GFP knock-in strategy facilitates the capacity to express
GFP based on endogeneous Epo gene expression confined to a rare
population, without worries about aberrant or ectopic transgene
expression. As a result, we identified REPs as peritubular
fibroblast-like interstitial cells concentrated at the cortico-medul-
lary junction, corresponding to our previous finding from the Epo-
GFP transgenic mouse studies [5,6].
In the history of Epo research, in situ hybridization is a classic
method to localize Epo mRNA; but extensive studies lead to
confusion of REPs’ whereabouts: peritubular interstitium, or a
tubular site [5]. Transgenic mice, created by integrating a marker
gene with regulatory sequences of the Epo gene, have provided a
powerful tool for accurate localization of REPs in the kidney
[6,8,11]. In mice bearing an Epo/SV40 T antigen transgene, REPs
were successfully identified but attempts to isolate REPs in vitro
failed [8,11]. Importantly, later transgenic mouse studies suggested
that a much wider (20-kb,) flanking region of the Epo gene was
needed for adequate levels of transgene expression in kidney
[5,6,36].
To induce Epo gene expression, pre-treatment to induce
hypoxia/anemia is usually required. These procedures, such as
bleeding or phenylhydrazine injection, are not always successful in
Figure 3. Cellular marker characterization of the GFP
+ kidney cells of Epo
GFP/D39E mouse. Dual immunostaining combined with confocal
microscopy indicating GFP-expressing cells are not endothelial (CD31, A), dendritic (MHCII, B), and tubular cells (E-cadherin, Movie S1). GFP-positive
interstitial cells express fibroblast-like markers (PDGFRb, C), but not myofibroblast marker (a-SMA, D). Kidney slices from P5 Epo
GFP/D39E mice were
stained with GFP (green) and the indicated antibodies directly labeled with phycoerythrin (PE, red) or indirectly labeled with Alexa 594 (red)
respectively. Merged images of the same kidney section are shown. DAPI: blue/nucleus; Scale bars: 25 mm.
doi:10.1371/journal.pone.0025839.g003
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using our Epo-GFP transgenic mouse [6]. The GFP
+ population of
the kidney cells from the transgenic mouse were not distinct under
FACS detection, despite that severe anemia was induced by
phlebotomy. Epo
GFP/D39E mice provide a handy and important
source: lacking the 39 enhancer demonstrated impaired hepatic Epo
expression and profound anemia (Hct value was about 18% in
newborn stage P4–6) and allowed us to directly sort REPs by FACS,
which are constantly and stably labeled with GFP fluorescence in
newborn kidneys. Moreover, considering the loose connections of
renal tissues and the decreased interstitial volume of the cortex, renal
tissues from newborns promised to be a better source of this rare cell
population than adult kidney [37]. What is important that newborn
REPs are fully functional with regard to Epo secretion, soon after
birth [9,23]. Indeed, newborn REPs (P4–6) displayed adult REPs
phenotypes: fibroblast-like (CD73
+/a-SMA
2) [28,29] with neuronal
marker expression (MAP2
+/NFL
+)[ 6 ] .
Figure 4. Co-localization of GFP and CD73 in the peritubular interstitial cells of the Epo
GFP/D39E kidneys. A–C Representitive images of
confocal microscopy of kidney sections from P5 Epo
GFP/D39E mice. B A high-power view, demonstrated that GFP and CD73 were mostly co-localized in
peritubular fibroblast cells (merged in yellow). Global merged view of the kidney sections from P5 Epo
GFP/D39E neonates (C), and Epo
D39E/wt littermates
(D). D Under normal conditions CD73 showed a wide expression spectrum in a variety of cellular types including a few interstitial fibroblasts in the
kidney. C During anemia note that CD73
+ cells appeared to be increased mainly in the peritubular fibroblast population. GFP: green; CD73: red; DAPI:
blue/nucleus; merged: yellow. Scale bars: 20 mm.
doi:10.1371/journal.pone.0025839.g004
Table 1. Expression of cellular markers in REPs by multiple
immunostaining methods.
Surface marker Specificity in renal cells Expression Methods
E-cadherin Tubule - CM*, FACS
CD31 Endothelium - CM, FACS
MHCII Dendritic cell - CM, FACS
CD73 Interstitial fibroblast + (63%) CM, FACS
a-SMA Myofibroblast - CM
PDGFRb (CD140b) Interstitial fibroblast + (50%) CM, FACS
*CM: Confocal Microscopy.
doi:10.1371/journal.pone.0025839.t001
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GFP coupled with marker molecule analyses revealed that REPs
are localized in the deep renal cortex, form a network around
tubules and adjacent capillaries with their processes, and express
fibroblast markers CD73, PDGFRb and soluble guanylyl cyclase
(sGC) (data not shown) but not other cell markers CD31, MHCII
or E-cadherin. Surface expression of these molecules on REPs was
verified by both confocal microscopy and flow cytometry.
Therefore, all of these data support a widely accepted notion that
REPs are peritubular fibroblast-like interstitial cells [6,10], and
resolves earlier conflicts on the cell identity in the literature [5].
Fibroblasts are considered to be an easy cell type to cultivate.
However our attempts to culture REPs were not successful. It is
interesting to consider that REPs are a type of fibroblasts in a
resting state, and when induced to proliferate (signified by a-SMA
expression), they lose their ability to produce Epo [38,39], such as
the case for renal fibrosis and renal anemia. Concurring with our
previous finding that adult REPs express neuronal markers [6], we
confirmed Map2 and Nfl mRNA expression in FACS-sorted REPs
from P4–6 newborns. These observations further support the
notion that REPs are unique fibroblast-like cells.
Association with CD73 during anemia
Our histological and flow-cytometrical examinations revealed
that REPs constitute grossly 0.2% of total kidney cells, with 63%
co-expressing CD73 in the case of our Epo
GFP/D39E mice (Hct 18%
Figure 5. Isolation of REPs from the P4–6 Epo
GFP/D39E anemic kidneys. A Cell purification protocol for a rare population of REPs from kidney. B,
upper panel Representative FACS scatter plot of kidney cells from pooled P4–6 Epo
GFP/D39E neonates demonstrating GFP
+ cells above the gate (set
using Epo
D39E/wt control cells). B, lower panel Assessment by FACS of percentage of GFP
+ and CD73
+ fractions in the kidney cells from P4–6 anemic
Epo
GFP/D39E neonates. Pooled results were from three independent experiments. Note CD73 expression divides GFP
+ cells into two parts: CD73
+ and
CD73
2. C Representative confocal microscopy of the FACS-sorted GFP
+ cells (REPs) with anti-GFP immunostaining. Scale bar: 5 mm. D Analysis of
relative Epo mRNA levels by qRT-PCR (Hprt as a loading control) in FACS-purified GFP
+ or the remaining GFP
2 kidney cells from P4–6 Epo
GFP/D39E mice;
CD73
+ vs. CD73
2 fractionated cells were also evaluated. The data shown are from four experiments, each performed in duplicate. nd: not detectable;
*p,0.05.
doi:10.1371/journal.pone.0025839.g005
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PLoS ONE | www.plosone.org 7 October 2011 | Volume 6 | Issue 10 | e25839at P4–6 newborn stage). In the non-anemic kidneys, only a few
REPs, composed of both CD73
+ and CD73
2, can be observed in
the juxtamedullary layer of the cortex. These cells probably
represent a basal level of Epo production under normal conditions,
which is required for daily production of red blood cells in normal
individuals. In anemic kidneys both CD73
+ and CD73
2 REPs are
robustly increased in a pattern that spreads outward from the deep
cortex toward the capsule and the inner medullar.
qRT-PCR revealed a 100-fold enrichment of Epo mRNA in the
GFP
+ fraction, but no enrichment in the CD73
+ fraction,
compared with the unsorted total kidney cells. CD73 has a wide
expression profile in renal cortex, occupying roughly 3% of the
total kidney cells at P4–6 newborn stage based on our FACS study.
In addition to the interstitial cells, such as fibroblasts, T-, B-
lymphocytes, many parenchymal cells e.g. glomorular mesangial,
proximate tubular (brush board), collecting duct cells etc. also
Figure 6. Expression profile of cellular oxygen-sensing and hypoxia-inducible molecules in the isolated REPs. qRT-PCR analysis of the
genes related to hypoxia response using RNA extracted from the sorted GFP
2 and GFP
+ renal cells from P4–6 Epo
GFP/D39E mice. Hprt as a loading
control *p,0.05. Data are for three experiments performed in duplicate. A Four genes related to cellular oxygen-sensing; B three Hifa isoforms. Also
note that HIF1a targets: Pgk1, Phd2 are not enriched in the GFP
+ fraction (REPs). C Three transcript variants of Hif3a in the purified GFP
+ fraction
(REPs), using a method for exponential PCR amplification at a fixed threshold (see also Materials and Methods).
doi:10.1371/journal.pone.0025839.g006
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the anemic kidney section with the non-anemic one, it seems that
anemia increases the number of CD73
+ cortical interstitial
fibroblasts but not other types of CD73
+ cells. Because cortical
fibroblasts are rare population, among all of the CD73
+ cells, the
percentage of CD73 fraction did not change much in anemic
kidneys compared with non-anemic kidneys. The heterogeneity of
CD73 expression in REPs may reflect different functional or
matured stages during anemia [39]]. Recently, it has been
reported that loss-of-CD73 does not affect the expression of Epo
[40]. Our data that only a part of REPs express CD73 in anemic
kidneys seem to conform this finding that the loss of CD73 has not
impact on renal erythropoietin induction under hypoxia.
Expression profile of oxygen sensor molecules and
transcriptional determinants in REPs
Clinically, congenital defects of the oxygen-sensing pathway
have been reported including VHL, PHD2 and HIF2A mutations
that cause secondary erythrocytosis through the EPO gene over-
expression [1,7]. PHD2 inactivation is sufficient to induce near
max. renal Epo production [41,42]; and recent RNAi-based
studies confirmed the major role of PHD2 in Epo regulation in vitro
as well as in vivo [43]. Human and rat PHD2 mRNA are
hypoxically induced by HIFs for negative feedback regulation
[44,45]. In the carbon monoxide exposed rat, PHD3 protein was
detected and co-localized with HIF2a in cortical interstitial cells of
the kidneys [46]. Phd2, 3 are the targets of HIF1a [4]. In this study,
we examined four genes encoding oxygen-sensor molecules
(PHD1–3 and FIH1) and did not observe any enrichment in
REPs compared with other cells of the anemic kidneys in our gene
expression profiling. This may be because all of these four genes
are ubiquitously expressed in kidney, with respect to various cell
types of the kidney.
As described above, Hif2a, rather than Hif1a shows highly
REPs-specific expression patterns at the mRNA level. Interesting-
ly, Hif2a mRNA levels are particularly high in tissues that are
important for the systemic delivery of oxygen, for example the
lung, heart, endothelium and the carotid body [47–49]. Quite
recently, HIF2a protein expression has been shown in the
peritubular fibroblasts that express Epo and CD73 in rat kidneys
[30]. Preferential binding of HIF2a protein to the HRE within the
native Epo gene 39 enhancer has been also confirmed in
hepatocytes [50]. As renal Epo expression does not depend on
the Epo gene 39 enhancer [23], the existence of a possible renal
enhancer with a different HRE awaits investigation.
Enrichment of Hif3a mRNA was also observed in the REPs.
Transcripts of all of the three splicing variants (Nepas, Ipas and
Hif3a)o fHif3a could be detected in newborn REPs (P4–6), where
Nepas seems to be the dominant form of the three. Nepas and Ipas
have been demonstrated to be hypoxia-induced factors due to the
presence of functional HREs upstream of Exon1a, and act as
negative regulators of the HIF pathway. Both Ipas and Nepas show
a cell-, and stage-specific expression pattern [21,22]. IPAS
(inhibitory PAS protein) has already been reported to work as a
negative feedback factor in a hypoxic condition in the cornea
[21,51], but there is no literature on its roles in hematopoiesis so
far. Our targeted Hif3a knockout mice (Hif3a
2/2) show an
impaired cardiovascular formation around birth. This phenotype
is possibly caused by over-expressed Endothelin-1 in pulmonary
endothelium. HIF3a (Nepas) was suggested to suppress HIF2a-
driven transcription of Endothelin-1 according to the localization
and reporter assays [22].
We were curious to see if a similar mechanism exists in Epo gene
regulation. We are starting to explore the function of HIF3a in
erythropoiesis by examination of our established Hif3a
2/2 mice
[22]. Hif3a
2/2 mice were viable and fertile without abnormalities
under normal conditions. Based upon our preliminary data in
mouse hypoxia experiments, it appeared that Epo transcript
showed up-regulated tendency in Hif3a
2/2 kidneys, in contrast to
the wild type counterparts. In a recent review, McIntosh et al. also
mentioned an erythropoietic phenotype in their independent
Hif3a
2/2 mice [52]. We, therefore, hypothesized HIF3a-related
negative regulation is also necessary in renal Epo production
during hypoxia/anemia. By this, homeostasis of red blood cell
mass might be maintained to prevent erythrocytosis and
thrombosis occurring in animals and human beings. HIF response
to hypoxia is complex. A recent report has demonstrated that
human HIF3A gene expression is induced by hypoxia through
activation of HIF1a but not HIF2a [53]. It raises the possibility
that in REPs, Hif3a mRNA expression might be up-regulated by
HIF2a, because REPs preferentially express Hif2a rather than
Hif1a.
Recently a renal cell line producing Epo with a hypoxia-
dependent manner has been successfully established from a patient
suffering from renal cancer [12]. Here, we report for the first time
on isolation or purification of REPs in vivo. Our mouse enables the
purification of a rare cell population specific for renal Epo
expression during anemia and a detailed examination of the
hypoxia-dependent aspect of the cells. Finally, we report the novel
finding that Hif2a and Hif3a (but not Hif1a) mRNA are
preferentially expressed in REPs. Combined with recent evidence
in vivo about the role of HIF2a in erythropoiesis, we propose a
hypothesis: positive regulation by HIF2a and negative regulation
by HIF3a may be necessary for correct renal Epo induction during
hypoxia/anemia.
Materials and Methods
Generation of Epo
GFP/D39E mice
All mice used were from a C57BL/6 genetic background and
were strictly kept in the specific-pathogen-free conditions. All
experiments were conducted in accordance with the regulations of
The Standards for Human Care and Use of Laboratory Animals
of Tohoku University. The protocol was approved by the
Committee on the Ethics of Animal Experiments of Tohoku
University (Permit Number: 21-Idou-144 and 22-Idou-113).
Epo
GFP/D39E mice were generated by mating mice heterozygous
for Epo
GFP/wt with mice homozygous for deletion of the 39enhancer
(Epo
D39E/D39E) [23]. Genotyping was performed by polymerase
chain reaction (PCR) with the primer sets listed in Table 2. From
this mating, half of the offspring would be Epo
GFP/D39E mice. These
mice are genetically deficient in Epo gene 39enhancer activity and
had anemia within two weeks after birth.
Hematological analysis
Whole blood was collected from the carotid arteries, and
hematopoietic indices were measured using an automatic blood
cell analyzer (Nihon Koden).
Immunostaining
Kidneys were immersion-fixed in 4% paraformaldehyde
(Nakarai Tesque) for 3 hours at 4uC and embedded in OCT
compound (Sakura Finetechnical). Frozen sections 20 mmi n
thickness were incubated with primary antibody for 16 hours at
4uC, and detected by Alexa Fluor 488 (Molecular Probes) or Alexa
Fluor 555 (Molecular Probes) conjugated anti-IgG as second
antibodies. Color detection was performed using diaminobenzi-
dine as a chromogen (brown color staining). Nuclei were stained
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were observed using the LSM510 confocal imaging system (Carl
Zeiss).
All of the primary antibodies were diluted 1:500 in blocking
solution (Dako) as follows: Anti-GFP (MBL); Biotinylated Anti-E-
Cadherin (R&D systems); anti-CD31 (BD Pharmingen); phycoer-
ythrin (PE) anti-CD73 antibody (BD Pharmingen); Alexa Fluor
647 Anti-CD73 (Biolegend); anti-a-SMA (Abcam); Allophycocya-
nin (APC) anti-CD140b (PDGFRb) (Biolegend); APC anti-MHCII
(eBioscience).
FACS analysis and cell sorting
Epo
GFP/D39E anemic newborns were sacrificed at P4–6. The
kidneys were collected in PBS from several litters and teased away
from their surrounding tissues. Single cell suspension was prepared
using dispase (1.25 mg/mL; Invitrogen) in PBS–15% FCS for
60 min at 37uC followed by washing in DMEM-Ham’s F-12–10%
FCS and passing through a nylon mesh to remove any clumps.
This cell preparation was approximately 85% single viable cells.
Whole kidney was analyzed and sorted on the flow cytometer
(FACSAria, Becton Dickinson). The effectiveness of each FACS
separation was assessed by immediately resorting an aliquot of
GFP
+ and GFP
2 cells (data not shown). Greater than 75% of the
GFP
+ population resorted to the same gate used in the initial sort.
qRT-PCR analysis
Total RNA was extracted from FACS-purified cells using
Isogen reagent (Nippon Gene), according to the manufacturer’s
protocol. RNA was then concentrated using RNeasy MinElute
columns (Qiagen) and first strand cDNA synthesis was performed
using the SuperScript III First Strand Synthesis System for RT-
PCR (Invitrogen).
Primers for amplifying 100–300 bp of each PCR product were
used (Table 2). PCR reactions were SYBR Green programmed and
carried out using qRT-PCR Mastermix (Takara). Each sample was
analyzed in duplicate or triplicate. The data were normalized by
subtracting the difference of the CT values between the target genes
of interest (Tgene) and that of Hprt mRNA, thereby obtaining a
DCT (Tgene CT2HPRT CT). Relative expression (fold induction)
was calculated as 2
2(SDC
T
2CDC
T
) where SDCT2CDCT is the
difference between the sample DCT (GFP
+ cells) and the control
DCT (GFP
2 cells). Both target gene and Hprt reactions approached
100% efficiency as determined by standard curves. PCR products
were analyzed by dissociation curve and on agarose gels to check
that a single band was amplified.
The molar ratio was calculated as previously described [33,34]:
molar ratio=[La6(1+Ea)
CTa]/[Lb6(1+Eb)
CTb]. La and Lb indicate
lengths of the amplicon for 1a and 1b transcripts, respectively. Ea
and Eb indicate the amplification efficiency of a primer set for 1a
and 1b transcripts, respectively. CTa and CTb indicate the
numbers of threshold cycles for the 1a and 1b transcripts,
respectively.
Statistics
Statistical analysis was performed between samples and controls
using t-test (two tailed, unequal variance, p#0.05 cut-off).
Supporting Information
3D-movie of REPs and their spatial coordination, were made by
compiling images collected using a Zeiss LSM 510 confocal
microscope. One z-slice of the stack is shown in Movie S1.
Supporting Information
Movie S1 3D image of REPs by confocal laser-scanning
microscopy. Kidney sections from P5 Epo
GFP/D39E newborn
were co-stained with anti-E-cadherin to label the tubular cells.
GFP: green; E-cadherin: white; DAPI: blue/nucleus. Scale bar:
20 mm.
(MOV)
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Use Sequence (59-39)
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GFP allele ACTCTCGGCATGGACGAGCTG
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D39E allele ACATGGTCCTGCTGGAGTTC
ACACACTCCCAGCAAATTCC
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qRT-PCR for Ipas mRNA TCCACGATGGTGCTACTCTG
TGTCCTTCACTCCCTCCTAG
qRT-PCR for Nepas mRNA CTGCAGCGCGTGAGGTCG
CTTTTTCCACCTGGTTCCAC
qRT-PCR for Hif3a
mRNA (variant 1)
ACCAAGACAGGTCGAACACC
TTTTCCACCTGGTTCCACTC
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qRT-PCR for Hprt mRNA GTTGGATACAGGCCAGACTTTGT
CCACAGGACTAGAACACCTGC
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